ABCG2 and acute myeloid leukemia: Despite the heterogeneity of employed methods (m-RNA quantification, protein expression by flow cytometry or immune-cytochemistry, protein function by efflux of naturally fluorescent substrates) and the lack of standardization that makes data comparison difficult, many studies in the past decades have reported a relationship between ABCG2 overexpression and poor clinical outcomes in AML.